SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-009042
Filing Date
2020-05-15
Accepted
2020-05-15 14:30:50
Documents
58
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1016115
2 ex31-1.htm EX-31.1 17408
3 ex32-1.htm EX-32.1 7565
  Complete submission text file 0001493152-20-009042.txt   7248564

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE obmp-20200331.xml EX-101.INS 1177412
5 XBRL SCHEMA FILE obmp-20200331.xsd EX-101.SCH 82155
6 XBRL CALCULATION FILE obmp-20200331_cal.xml EX-101.CAL 51586
7 XBRL DEFINITION FILE obmp-20200331_def.xml EX-101.DEF 280687
8 XBRL LABEL FILE obmp-20200331_lab.xml EX-101.LAB 507555
9 XBRL PRESENTATION FILE obmp-20200331_pre.xml EX-101.PRE 349196
Mailing Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820
Business Address 8000 INNOVATION PARK DR, BATON ROUGE BATON ROUGE LA 70820 225-578-7555
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 20883981
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences